Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
151,865,218
-
Number of holders
-
206
-
Total 13F shares, excl. options
-
111,322,127
-
Shares change
-
+10,359,031
-
Total reported value, excl. options
-
$5,410,179,736
-
Value change
-
+$503,359,137
-
Put/Call ratio
-
32%
-
Number of buys
-
131
-
Number of sells
-
-67
-
Price
-
$48.63
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q3 2020
245 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q3 2020.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111,322,127 shares
of 151,865,218 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (33,493,708 shares), Matrix Capital Management Company, LP (13,115,090 shares), VANGUARD GROUP INC (7,066,107 shares), BlackRock Inc. (5,310,912 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,840,398 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2,952,304 shares), GILDER GAGNON HOWE & CO LLC (2,397,279 shares), Artisan Partners Limited Partnership (2,053,982 shares), Neuberger Berman Group LLC (1,847,952 shares), and Senator Investment Group LP (1,750,000 shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.